Radnostix Inc (INIS) KPIs and segments
Close on Oct 19, 2026Market cap $24.87MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Radnostix's business
Radnostix's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Theranostics Products($M)2 | 1.08 | 1.40 | 1.66 | 1.48 | 1.91 | 1.79 | 1.75 | 2.18 | 2.17 | 1.91 | 1.81 | 1.53 | |
United States($M) | 2.09 | 2.03 | 1.75 | 1.04 | 1.41 | ||||||||
Non-US($M) | 0.09 | 0.14 | 0.16 | 0.77 | 0.12 | ||||||||
Calibration & Reference Products($M) | 1.06 | 0.88 | 0.95 | 0.96 | 1.01 | 1.33 | 1.42 | 0.93 | |||||
Nuclear Medicine Products($M)2 | 1.01 | 1.33 | 1.42 | 0.93 | 0.41 | 0.77 | 1.24 | 1.05 | |||||
United States($M) | 0.64 | 0.23 | 0.54 | 0.97 | 0.83 | ||||||||
Non-US($M) | 0.28 | 0.18 | 0.23 | 0.27 | 0.22 | ||||||||
Cobalt Products($M)2 | 0.50 | 0.01 | 0.24 | 0.77 | 0.68 | 0.07 | 0.72 | 0.81 | 0.59 | 0.23 | 0.10 | 0.33 | |
United States($M) | 0.81 | 0.59 | 0.22 | 0.11 | 0.29 | ||||||||
Non-US($M) | 0 | 0.00 | 0.02 | 0.04 | |||||||||
Medical Device Products($M)2 | 0.04 | 0.09 | 0.05 | 0.07 | 0.06 | 0.05 | 0.01 | 0 | 0 | 0 | 0 | 0 | |
Non-US($M) | 0 | 0 | 0 | 0 | |||||||||
United States($M) | 0 | 0 | 0 | 0 | |||||||||
Fluorine Products($M)2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Non-US($M) | 0 | 0 | 0 | 0 | 0 | ||||||||
United States($M) | 0 | 0 | 0 | 0 | 0 | ||||||||
Earlier reporting (last reported 2023)1 | |||||||||||||
Theranostics Products($M) | 0.17 | 0.41 | 0.67 | 0.63 | 1.01 | 0.88 | 0.89 | 1.29 | 1.17 | 1.01 | 0.87 | 0.69 | |
Cobalt Products($M) | 0.06 | -0.25 | -0.18 | 0.25 | -0.10 | -0.15 | 0.20 | -0.05 | 0.10 | -0.07 | -0.24 | 0.09 | |
Fluorine Products($M) | -0.03 | -0.01 | 0.01 | -0.00 | 0.00 | -0.03 | -0.03 | -0.03 | -0.03 | 0.02 | -0.03 | -0.03 | |
Nuclear Medicine Products($M) | -0.04 | 0.27 | 0.24 | 0.04 | -0.38 | 0.01 | 0.17 | 0.07 | |||||
Calibration & Reference Products($M) | -0.10 | -0.12 | -0.12 | -0.10 | -0.04 | 0.27 | 0.24 | 0.04 | |||||
Medical Device Products($M) | -0.21 | -0.16 | -0.13 | -0.19 | -0.20 | -0.18 | -0.19 | -0.17 | -0.08 | -0.03 | -0.00 | 0 | |
Earlier reporting (last reported 2023)1 | |||||||||||||
Cobalt Products($M) | 0 | -0.11 | -0.02 | 0 | 0 | -0.01 | 0 | -0.04 | -0.04 | 0 | -0.04 | 0 | |
Fluorine Products($M) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Theranostics Products($M) | 0 | -0.05 | 0 | 0 | -0.00 | -0.05 | 0 | 0 | 0 | -0.09 | -0.00 | 0 | |
Medical Device Products($M) | 0 | -0.05 | -0.04 | -0.06 | 0 | -0.03 | 0 | 0 | 0 | -0.03 | 0 | ||
Calibration & Reference Products($M) | 0 | 0 | -0.26 | 0 | -0.06 | -0.02 | -0.02 | 0 | |||||
Nuclear Medicine Products($M) | -0.06 | -0.02 | -0.02 | 0 | 0 | -0.05 | 0.48 | -0.48 | |||||
Earlier reporting (last reported 2023)1 | |||||||||||||
Fluorine Products($M) | 4.74 | 4.77 | 4.77 | 4.80 | 4.82 | 4.85 | 4.88 | 4.90 | 4.93 | 4.95 | 4.98 | 5.01 | |
Calibration & Reference Products($M) | 2.96 | 2.84 | 2.90 | 2.71 | 2.93 | ||||||||
Nuclear Medicine Products($M) | 2.65 | 2.77 | 2.93 | 2.78 | 2.42 | 2.51 | 2.99 | 3.20 | |||||
Medical Device Products($M) | 0.92 | 0.79 | 0.70 | 0.70 | 0.65 | 0.61 | 0.55 | 0.55 | 0.55 | 0.55 | 0.55 | ||
Theranostics Products($M) | 0.73 | 0.99 | 1.12 | 1.29 | 1.36 | 1.21 | 0.99 | 1.12 | 0.93 | 1.12 | 0.85 | ||
Cobalt Products($M) | 0.22 | 0.32 | 0.26 | 0.72 | 0.12 | 0.19 | 0.17 | 0.19 | 0.27 | 0.47 | 0.27 | 0.39 | |
Earlier reporting (last reported 2023)1 | |||||||||||||
Earlier reporting (last reported 2024)2 | |||||||||||||
43 metrics have no data in the last 12 quarters — .
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-08-12.
See a number that looks wrong?